Form 8-K - Current report:
SEC Accession No. 0001213900-25-075972
Filing Date
2025-08-14
Accepted
2025-08-13 21:29:48
Documents
16
Period of Report
2025-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0252596-8k_180life.htm   iXBRL 8-K 37628
2 SALES AGREEMENT, DATED AUGUST 13, 2025, BY AND BETWEEN 180 LIFE SCIENCES CORP. A ea025259601ex1-1_180life.htm EX-1.1 241566
3 OPINION OF THE LOEV LAW FIRM, PC ea025259601ex5-1_180life.htm EX-5.1 13787
4 GRAPHIC ex5-1_001.jpg GRAPHIC 40223
  Complete submission text file 0001213900-25-075972.txt   626409

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20250813.xsd EX-101.SCH 3786
6 XBRL DEFINITION FILE atnf-20250813_def.xml EX-101.DEF 26628
7 XBRL LABEL FILE atnf-20250813_lab.xml EX-101.LAB 36679
8 XBRL PRESENTATION FILE atnf-20250813_pre.xml EX-101.PRE 25252
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0252596-8k_180life_htm.xml XML 5685
Mailing Address 2875 SOUTH OCEAN SUITE 200 PALM BEACH FL 33480
Business Address 2875 SOUTH OCEAN SUITE 200 PALM BEACH FL 33480 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251213860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)